Results for tag: "RSV Drug"

The RSV Drug market is a subset of the larger Respiratory Drugs market, which includes treatments for a variety of respiratory illnesses. RSV (Respiratory Syncytial Virus) is a common virus that can cause severe respiratory illness in infants and young children. RSV Drugs are used to treat the symptoms of RSV infection, such as coughing, wheezing, and difficulty breathing. These drugs can also help reduce the risk of complications from RSV, such as pneumonia and bronchiolitis. RSV Drugs are typically administered as an inhaler or nebulizer, and may also be available in liquid or pill form. Common RSV Drugs include bronchodilators, corticosteroids, and antiviral medications. These drugs are typically prescribed by a doctor and are available over-the-counter in some countries. Some companies in the RSV Drug market include GlaxoSmithKline, Merck, AstraZeneca, and Novartis. Show Less Read more